Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk
| Image |  |
|---|---|
| Description | scientific article published on 2 November 2017 |
| Author/s |
author: François Raffi Stéphane De Wit Hans-Jürgen Stellbrink |
| Publication date | November 2, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |